Jazz Pharmaceuticals Net Long-Term Debt 2010-2025 | JAZZ

Jazz Pharmaceuticals net long-term debt for the twelve months ending March 31, 2025 was $-0.016B, a 79.4% decline year-over-year.

  • Jazz Pharmaceuticals annual net long-term debt for 2024 was $0.375B, a 1308.93% decline from 2023.
  • Jazz Pharmaceuticals annual net long-term debt for 2023 was $-0.031B, a 94.67% decline from 2022.
  • Jazz Pharmaceuticals annual net long-term debt for 2022 was $-0.582B, a 115.04% decline from 2021.

Jazz Pharmaceuticals Net Long-Term Debt 2010-2025 | JAZZ

  • Jazz Pharmaceuticals annual net long-term debt for 2024 was $0.375B, a 1308.93% decline from 2023.
  • Jazz Pharmaceuticals annual net long-term debt for 2023 was $-0.031B, a 94.67% decline from 2022.
  • Jazz Pharmaceuticals annual net long-term debt for 2022 was $-0.582B, a 115.04% decline from 2021.